Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  pacritinib
Find trials that include:  Any drugs shown
Results 1-5 of 5 for your search:
Start Over
Oral Pacritinib Versus Best Available Therapy to Treat Myelofibrosis With Thrombocytopenia
Status: Active
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: PERSIST-2 (PAC326), NCI-2014-00893, NCT02055781
Pacritinib and Erlotinib Hydrochloride in Treating Patients with Metastatic or Locally Advanced Non-small Cell Lung Cancer after EGFR TKI Treatment
Status: Temporarily closed
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 201503052, NCI-2015-00399, J20001, NCT02342353
JAK Inhibitor before Donor Stem Cell Transplant in Treating Patients with Primary or Secondary Myelofibrosis
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 9033, NCI-2014-01882, NCT02251821
Pacritinib and Chemotherapy in Treating Patients with Acute Myeloid Leukemia and FLT3 Mutations
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: OSU-14169, NCI-2014-02436, NCT02323607
Pacritinib and Decitabine in Treating Patients with Intermediate-High Risk Myelofibrosis or Myeloproliferative Neoplasm/Myelodysplastic Syndrome
Status: Not yet active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 201510166, NCI-2015-01934, NCT02564536
Start Over